Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia

Technology appraisal guidance
Reference number: TA218
Published: 23 March 2011

NICE recommends new treatment for myelodysplastic syndromes

2011/048 NICE recommends new treatment for myelodysplastic syndromes

2011/048 NICE recommends new treatment for myelodysplastic syndromes

2011/048 NICE recommends new treatment for myelodysplastic syndromes
21 March 2011
(72.74 Kb 21 sec @ 28.8Kbps)

Adobe Acrobat reader required.

Adobe Acrobat reader required.